Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Salivary Gland Neoplasm Duct × Leuprolide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 16 Breast Neoplasms 4 Salivary Gland Neoplasms 1 Salivary Gland Neoplasm Duct 1 Prostate Adenocarcinoma 1 Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms, Male 1 Advanced Prostate Cancer 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06348264 2025-09-23

Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma

Peking University First Hospital

Phase 2 Recruiting

Salivary Gland Neoplasm Duct

Data powered by HemOnc (CC BY 4.0) Colophon ⚡